Platelets control liver tumor growth through P2Y12-dependent CD40L release in NAFLD-Reference-Cited by-同舟云学术

Platelets control liver tumor growth through P2Y12-dependent CD40L release in NAFLD

Published:2022-09 Issue:9 Volume:40 Page:986-998.e5
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Ma Chi^ORCID,Fu Qiong,Diggs Laurence P.,McVey John C.^ORCID,McCallen Justin^ORCID,Wabitsch Simon,Ruf Benjamin^ORCID,Brown Zachary,Heinrich Bernd,Zhang Qianfei,Rosato Umberto,Wang Sophie^ORCID,Cui Linda,Berzofsky Jay A.^ORCID,Kleiner David E.,Bosco Dale B.,Wu Long-Jun^ORCID,Lai Chunwei Walter,Rotman Yaron,Xie Changqing,Korangy Firouzeh,Greten Tim F.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference53 articles.

1. Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway;Barry;J. Biol. Chem.,1999

2. Adoptive transfer method to study platelet function in mouse models of disease;Bergmeier;Thromb. Res.,2014

3. Cutting edge: leukotriene C4 activates mouse platelets in plasma exclusively through the type 2 cysteinyl leukotriene receptor;Cummings;J. Immunol.,2013

4. XCR1(+) type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis;Deczkowska;Nat. Med.,2021

5. The effects of platelet accumulation in fatty liver disease;Diggs;Nat. Rev. Gastroenterol. Hepatol.,2019

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers;Metabolism;2024-11

2. Immunotherapy for hepatocellular carcinoma;JHEP Reports;2024-10

3. The Systemic Immune-Inflammation Index as an Independent Predictor of Survival in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Radiotherapy;Journal of Inflammation Research;2024-07

4. Interactions between platelets and the cancer immune microenvironment;Critical Reviews in Oncology/Hematology;2024-07

5. Tumor microenvironment RNA test to predict immunotherapy outcomes in advanced gastric cancer: The TIMES001 trial;Med;2024-07